Table 1.

Summary of gene lists used in this study to validate the performance of the proposed method in comparison with existing algorithms

Experiment description	Enriched miRNAs	Number of reported genes	Reference
HeLa cells transfected with miR-1	miR-1	96 repressed genes	[35]
HeLa cells transfected with miR-124	miR-124	174 repressed genes	[35]
HeLa cells transfected with miR-373	miR-373	65 repressed genes	[35]
LNCaP cells treatedwith pre-miR-1	miR-1	88 repressed genes and 80 upregulated genes	[36]
LNCaP cells treatedwith pre-miR-206	miR-206	83 repressed genes and 62 upregulated genes	[36]
LNCaP cells treatedwith pre-miR-27b	miR-27b	51 repressed genes and 157 upregulated genes	[36]
LNCaP cells transfected with pre-miR-32	miR-32	67 repressed genes	[37]
LNCaP cells transfected with pre-miR-148a	miR-148a	79 repressed genes	[37]
Genes predicted to be targets of 11 prostate miRNAs extracted from PRedNet	miR(1, 204, 205, 143, 145, 221, 222, 27b, 133b, 31, let-7	1854	[5,12,38]
Altered genes in prostate cancer using Taylor data		480 downregulated in prostate and 51 upregulated in prostate 269 downregulated genes in PCa samples that have BCR recurrence	[39]
Genes associated with BCR event in prostate cancer			[39]